Father of #Biohacking
Ja, Glutathion comp ist zu 100 % vegan
GLP-1/GIP, GLP-1/glucagon, and even triple agonists are the dominant focus, though the spectrum extends to other mechanisms as wellamylin, GIP antagonism, NK2 receptor agonism, and more, said DiMarchi Looking further ahead, DiMarchi sees potential for oral therapies, including oral peptides
Drugmakers have been racing to develop new and needle-free alternatives, with a plethora of pill versions being tested in clinical trials
N-acetylcysteine (NAC) has an established safety profile, having been used for many years for various potential clinical applications most notably for treatment of acetaminophen-induced hepatic injury
Writing in the Journal of the American Medical Association (JAMA), this week, a team of WHO directors and advisors argued that the availability of GLP-1 therapies should galvanize the global community to build a fair, integrated, and sustainable obesity ecosystem. Nearly one in five Americans have used a GLP-1 therapy at least once